Savannah Wiegel
Savannah Wiegel distinguishes herself through a clinical translation lens that connects advanced genomic technologies to patient outcomes, leveraging her multidisciplinary background in molecular biology and narrative medicine to make complex diagnostics accessible.
Clinical Genomics Focus
Wiegel consistently examines how emerging sequencing technologies solve diagnostic challenges in pediatric and cancer care, as demonstrated in her coverage of long-read genome sequencing identifying RFX3 haploinsufficiency in a patient with autism spectrum disorder and intellectual disability. She analyzes epigenomic research uncovering new acute myeloid leukemia subgroups and associated drug sensitivities, emphasizing therapeutic implications over technical details. Her reporting on CRISPR screening applications identifies host factors influencing HIV infection while highlighting potential antiviral targets like PI16 and PPID proteins.
Infectious Disease Applications
She connects fundamental virology research to clinical applications, covering how epitope-editing strategies and targeted antibodies could replace toxic DNA-damaging agents in stem cell therapies. Wiegel documents rare disease research initiatives through events like CNBC Cures, featuring FDA perspectives and industry stakeholders addressing unmet medical needs. Her work on microbial ecosystems extends to gut health research and ancient human virology through coverage of Denisovan genetic studies.
Technology Translation Approach
Wiegel specializes in explaining how new biotechnologies solve specific research problems, evidenced by her reporting on bioanalytical antibodies, mass spectrometry systems, and organoid research platforms. She maintains GEN's editorial standard of clearly articulating "what technology is used, what results were achieved, and why these matter for the field". Her conference coverage synthesizes key scientific developments while identifying actionable insights for researchers and clinicians.
Therapeutic Development Angle
She consistently frames research through therapeutic development pathways, as seen in her analysis of how elevated PI16 or PPID levels restrict aggressive HIV strains. Wiegel examines cancer treatment innovations by focusing on drug sensitivity patterns within newly identified genomic subgroups rather than cataloging mutations. Her reporting on ferroptosis-inducing silica nanoparticles demonstrates how mechanistic cancer biology research informs novel treatment approaches.
4 more health journalists.
Aislinn Antrim
Aislinn Antrim is an associate editorial director at Pharmacy Times and a journalist who connects clinical advances, regulation, and the changing role of pharmacists. She writes pharmacy-centered health coverage on chronic disease therapeutics, specialty and oncology care, workforce pressures, and advocacy. Her reporting explains FDA actions, policy shifts, drug pipelines, and the real-world effects of new evidence on patient care and pharmacy practice. She often uses interviews and expert conversations to show how pharmacists improve adherence, manage side effects, navigate access and benefits, and coordinate care with prescribers. She also covers burnout, staffing strain, and the future of pharmacy practice, with an eye on how policy and economics shape work at the dispenser.
Alex Cabrero
Alex Cabrero is an Emmy award-winning KSL TV reporter who covers where health, safety and community life meet, always focused on how decisions and events affect everyday people. He has been with KSL since 2004, bringing long experience in breaking news, public service coverage and human-centered features. His beat includes public health, emergency response, technology, local infrastructure, environment and science, framed through community well-being and resilience. He reports on issues like mental health initiatives, law enforcement staffing, environmental hazards, rescues, wildfire detection tools, land-use fights and scientific discoveries, making technical and policy details clear for a general audience. He also produces many positive, everyday-life features on families, veterans, farmers, sports and local traditions. His style is direct and conversational, often built around a central person or family whose experience carries the story across TV, digital and social platforms.
Allison Palmer
Allison Palmer stands out for turning complex microbiome and brain-health research into clear, service stories tied to everyday habits. She covers health, wellness and lifestyle topics for The Sacramento Bee, focusing on emerging trends that help readers build positive, sustainable routines. Her reporting on the gut microbiome and healthy aging uses vivid case studies, including a rare supercentenarian, to connect diet, bacterial communities and longevity to daily eating choices. Another strand of her work examines oral bacteria and brain health, linking gum infections to changes in brain tissue and to simple oral-care practices. Since 2024, her wellness coverage has appeared across the McClatchy network, alongside pieces on technology, travel, lifestyle and commerce. She favors reported explainers with direct takeaways, keeps scientific detail intact, and strips away jargon to help readers build realistic long-term habits.
Alyssa Kelly
Alyssa Kelly reports on health and emotional local stories that show how everyday experiences shape people’s sense of safety and wellbeing. They work in the digital newsroom at TV6 & FOX UP, contributing text and video pieces on community life and public interest topics. Their beat centers on health and safety in ordinary settings, especially outdoors, and on animal and family stories tied to wellbeing and memory. They cover issues like tick exposure during routine park visits and long-term pet disappearances and reunions, using specific details, clear timelines, and direct quotes to make the stakes feel immediate and personal. Kelly’s headlines often foreground quoted phrases from families and pet owners, giving their reporting a conversational, human-centered tone. They also collaborate with other reporters on health and safety stories that connect individual cases to wider public concerns.